Luspatercept Reduces Blood Transfusions in MDS and Beta-Thalassemia Luspatercept Reduces Blood Transfusions in MDS and Beta-Thalassemia

A novel agent reduced the need for blood transfusions in two separate patient populations: myelodysplastic syndromes (MDS) and beta-thalassemia.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news